Codes / ICD10CM / Q85.0

Q85.0 Neurofibromatosis (nonmalignant)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Neurofibromatosis (nonmalignant)

Summary

Neurofibromatosis is a genetic disorder marked by the growth of noncancerous tumors along nerves in the skin, brain, and other body systems. These tumors, called neurofibromas, can vary in size and location, potentially leading to a range of symptoms depending on their impact on surrounding tissues.

Causes

Neurofibromatosis is caused by mutations in specific genes that regulate cell growth and nerve development. The condition is typically inherited in an autosomal dominant pattern, meaning a single mutated gene from a parent can cause the disorder. Spontaneous mutations may also occur without a family history.

Risk Factors

  • Genetic Inheritance: A family history of neurofibromatosis increases the risk of developing the condition.
  • Spontaneous Mutations: New genetic mutations can arise even without a family history, contributing to cases.

Symptoms

  • Café-au-lait spots (light brown skin patches)
  • Neurofibromas (soft, benign tumors on or under the skin)
  • Freckling in armpits or groin areas
  • Lisch nodules (small bumps on the iris of the eye)
  • Skeletal abnormalities such as scoliosis
  • Learning disabilities or attention issues in some cases

Diagnosis

Diagnosis involves a clinical evaluation of visible symptoms, including skin changes and tumors, combined with genetic testing to identify mutations associated with the condition. Imaging studies like MRI or CT scans may be used to assess tumor locations and impacts on surrounding structures.

Treatment Options

  • Monitoring: Regular check-ups to track tumor growth and symptom changes.
  • Surgical Removal: For tumors causing pain, functional impairment, or cosmetic concerns.
  • Pain Management: Medications or therapies to address discomfort from tumors.
  • Rehabilitation: Physical or occupational therapy for mobility or functional issues.

Prognosis and Follow-Up

Prognosis varies based on tumor location and associated complications. Regular follow-up with healthcare providers is essential to monitor for new symptoms, manage complications, and adjust treatment as needed. Early intervention can improve outcomes for many individuals.

Complications

  • Chronic pain from tumor growth
  • Nerve compression leading to weakness or numbness
  • Skeletal deformities like scoliosis
  • Increased risk of certain benign or malignant tumors in rare cases
  • Psychological or social challenges due to visible symptoms

Lifestyle & Prevention

  • Genetic Counseling: For individuals with a family history to understand inheritance risks.
  • Regular Screenings: To detect and manage complications early.
  • Support Networks: Connecting with patient groups or mental health resources for coping.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms appear, such as rapid tumor growth, unexplained pain, changes in vision or hearing, or signs of nerve compression. Prompt evaluation can help address issues before they progress.

Tips for Medical Coders

Document the presence of neurofibromas, skin changes (e.g., café-au-lait spots), and any associated complications. Ensure clinical notes support the diagnosis and specify whether the condition is inherited or spontaneous. Include details on tumor locations or symptoms to justify code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

Q85.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.